The purpose the research is to evaluate the safety and efficacy of injection of adipose allograft matrix (AAM) to the small joints of the hand for treatment of early stage osteoarthritis. The hypothesis is that use of AAM injected directly into the joint will show improvements in pain and disability while providing a safe, off-the-shelf alternative which can obviate the need for, and risks associated with, current treatment options with autologous fat transfer. As standard of care, routine strength, pain scale scores (VAS) and range of motion will be recorded, a baseline disability survey (DASH score) will also be administered. After these have all been recorded and administered in a separate visit the patient will undergo the lipofilling procedure. The subject population will include patients over the age of 18 who present with joint pain of the hand with radiographic evidence of osteoarthritis.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Range of Motion
Timeframe: Pre-procedure
Range of Motion
Timeframe: 6 weeks
Range of Motion
Timeframe: 6 month
Range of Motion
Timeframe: 12 months
Strength Measures
Timeframe: Pre-procedure
Strength Measures
Timeframe: 6 weeks
Strength Measures
Timeframe: 6 months
Strength Measures
Timeframe: 12 months
Pain scale scores
Timeframe: Pre-procedure
Pain scale scores
Timeframe: 6 weeks
Pain scale scores
Timeframe: 6 months
Pain scale scores
Timeframe: 12 months
Disability Measurement
Timeframe: Pre-procedure
Disability Measurement
Timeframe: 6 weeks
Disability Measurement
Timeframe: 6 months
Disability Measurement
Timeframe: 12 months
Patient satisfaction
Timeframe: Day of procedure
Patient satisfaction
Timeframe: 6 weeks
Patient satisfaction
Timeframe: 6 months
Patient satisfaction
Timeframe: 12 months